Introduction
Asthmatic airw ays are hype rresponsive, contain an inc re ased amount of airw ay smooth muscle and are infiltrate d by a varie ty of inflammatory ce lls, including eosinophils and T-lymphoc ytes. It is now w idely acce pte d that both the incre ased smooth muscle bulk and inflammatory c ell products c ontribute to airw ay hyperresp onsive ness. The re is grow ing e videnc e that inflammatory c ell products not only alter the contractility of airw ay smooth muscle ce lls (ASMC) but also the ir adhesion molecule ex pression, prolife ration and me diator sec retion. 1 -4 Many groups have demonstrate d that eosinophil numbers and le vels of their sec re te d granule prote ins, both in airw ay fluid and in p eriphe ral blood, correlate w ith asthma se ve rity. Eosinophil densities in the lumen refle ct those in the inne r airw ay w all in fatal asthma. 5 Cytokines such as inte rleukin(IL)-5, p roduc ed mainly by T-lymphocytes, promote eosinophil rec ruitment, activation and survival in airw ay tissue s. 6 Onc e ac tivated, e osinop hils are a source of a w ide range of me diators, many of w hich are implicate d in altering airw ay smooth muscle function. The y release the pote nt smooth muscle c onstrictors le ukotrienes C 4 , D 4 and E 4 . The first dire ct link be tw ee n e osinophils and the induction of airw ay hype rre sponsivene ss w as established w he n w e de monstrated that supe rnatants from ac tivated e osinophils increase the contractile responses of human bronchial rings to histamine in v itro . 7 One e osinophil product know n to induce such in v itro hyperresponsive ness is PAF. 8 How e ver, eosinophils also rele ase a varie ty of grow th factors and c ytokine s know n to modulate other functions of ASMC. These include the cytokines tumour necrosis factor-a (TNF-a ) and IL-1b , w hich are p re sent in increased amounts in the airw ay fluid of asthmatics. TNF-a and IL-1b have a variety of effe cts on ASMC. The y modulate ASMC proliferation 9 ,1 0 and inc rease ASMC adhesion molecule ex pression. 1 More re ce ntly TNF-a and IL-1b have also bee n show n to induce ASMC to release cytokines and che mokine s, including eotax in and granulocyte-microphage colony stimulating factor (GM-CSF), implic ated in the re cruitme nt and survival of eosinophils. 11 ,12 Since eosinophils release products that induce a varie ty of change s in airw ay smooth muscle and the y are found in this smooth muscle layer, the nature of the inte rac tion betw ee n these tw o c ell-types needs to be investigate d. In this study w e investigate d the adhesion of human e osinophils to human ASMC in culture. The adhesion molec ule s involved and the effects of the cytokines TNF-a , IL-1b and IL-5 on this adhesion w e re studied.
Materials and methods

Materials
All ce ll c ulture requireme nts w ere obtained from Trac e Bioscie nce s (Sydne y, Australia ) ex cept for DMEM, penic illin, stre ptomycin, amphote ric in B w hich w ere supplied by Gibco BRL (Life Te chnologie s, Melbourne, Australia ). Antibodies to ICAM-1 (clone LB-2, Camfolio and HA58, PharMingen Inte rnational), VCAM-1 (E1 /6, Camfolio and 51-10C9, PharMinge n International) and irre le vant antibodie s of the same isotypes w ere supplie d by Be cton Dickinson (Sydne y, Australia ) in PBS w ith £ 0.09% NaN 3 and w ere dilute d just prior to use in RPMI-1640. Rec ombinant human TNF-a and IL-Ib w e re supplie d by R&D Systems Inc (Minneapolis, MN, USA), re constituted in PBS w ith 0.1% w /v bovine se rum albumin (BSA; Sigma-Aldrich, Australia ) at 10 m g /ml and aliquots store d at -20°C. Re combinant human IL-5 w as obtained from PharMingen Inte rnational (San Die go, CA, USA), aliquots w e re store d at -70°C at 50 ng /m l in PBS w ith 0.1% BSA. All thre e cytokines w e re dilute d imme diately be fore use in RPMI-1640.
Human airway smooth muscle cell isolation and culture
Human lung w as obtaine d from patients undergoing either surgical re se ction or lung transplantation. Human airw ay smooth muscle ce lls w ere pre pare d as desc ribed pre viously by Haw ker e t a l. 3 Brie fly, smooth muscle bundle s (ex plants ) w e re disse cte d out of bronchial se gments, w ashe d thoroughly and transferred to culture flasks in DMEM supp le mented w ith 10% FBS, L-g lutamine (4 mM) and antibiotics (penicillin 20 U/l, streptomycin 20 m g /ml and amphotericin B 2.5 m g /ml) and maintaine d at 37°C in a humidifie d 5% CO 2 in air atmosphere. Medium w as changed e very 5 days until the airw ay smooth muscle ce lls (ASMC) grew to conflue nce , w he n the y w ere passage d using trypsin -EDTA. ASMC at passage s 3 -7 w ere use d in the ex perime nts described below.
Prior to comme nce ment of ex p eriments the me dium on c onfluent ASMC w as changed to RPMI-1640 suppleme nted w ith 10% (v /v ) heat-inactivate d FBS, Hepe s 2 mM, L-glutamine 2 mM and gentamycin 20 m g /ml (RPMI) for at le ast 24 h prior to harvest. The ASMC w ere then harvested using trypsin -EDTA, w ashe d thoroughly and plated into 4-w ell slide-w ells at 1.5 -2.5 ´10 5 ce lls /w ell in 0.5 ml RPMI and cultured for 2 days prior to the addition of eosinophils.
Eosinophil isolation
Eosinophils w e re isolated from 60-120 ml he parinize d pe ripheral blood collected from healthy volunte ers using modific ations of the methods of Hanse l and colle ague s. 13 Briefly, the blood w as mix ed 5:1 w ith 6% (w /v ) high molec ular w eight dex tran in normal saline and the red ce lls allow e d to se dime nt for 40 min at room te mperature. The leucocyteenriched frac tion w as colle cte d and underlayere d w ith perc oll d 1.088 g /ml and spun at 700´g for 20 min at room tempe rature. Le ucocytes at the bottom of the gradient immediately above and in the red ce ll pe lle t, w ere c ollec te d and the re d c ells lyse d w ith 5´the collected ce ll volume of lysis buffer (0.82% w /v NH 4 Cl, 0.1% w /v K 2 CO 3 , 0.1 mM EDTA) for 15 min at 4°C. The remaining leucocyte s w e re w ashe d thoroughly, inc ubate d w ith magne tic mic robe ads coated w ith antibody to CD16 for 30 min at 6°C and c ells ex pre ssing CD16 (neutrophils ) remove d using a MACS c ell separator. With this me thod eosinophils w ere isolate d to 95% purity and w ith 98% viability as assessed by Kimura Light staining and trypan blue ex clusion, respec tively. The eosinophils w ere then imme diately w ashe d 2´w ith sterile RPMI and added to the ASMC in slide-w ells at 1.5-2.5 ´10 5 e osinophils /w ell and c o-c ulture d at 37°C in a humidified 5% CO 2 in air atmosphe re for up to 20 h as detailed below.
Slide-well processing and assessment of eosinophil adhesion
At the appropriate harvest time the slide-w e lls w ere gently rocked and all the c ulture me dium remove d from each w ell. The ce ll laye r in the w ells w as the n gently w ashed 3´w ith RPMI, draine d, fix ed in 100% me thanol and air-dried. The c ells still adhering to the bottom of the slide-w e ll w ere stained w ith KimuraLight and the number of eosinophils attached to the ASMC laye r counted in 20 fie lds of vie w (10 fie lds across and 10 fie lds dow n ) in each w ell using light mic rosc opy and 200´magnification.
Time course
In orde r to determine the te mporal pattern of eosinophil adhe sion to ASMC, e osinop hils w e re adde d to ASMC in slide-w ells and duplicate slide-w ells proce sse d imme diately or afte r 0.5, 1, 2, 4, 8, 16 and 20 h of c o-c ulture .
Adhesion molecule identification
The role of the adhesion mole cules ICAM-1 and VCAM-1 on eosinophil adhesion to ASMC w as determine d by incubating ASMC in duplicate slide-w ells w ith antibodie s (1.0, 3.0 or 10.0 m g /ml) to either ICAM-1, VCAM-1 or irre le vant antibodies of the same isotype , for 30 min at 37°C prior to the addition of the eosinophils. The slide-w ells w e re then proc essed after 2 or 20 h of co-culture.
Effect of cytokines
IL-1b a n d TNF-a .
The effects of the cytokines IL-1b (0.1, 1.0 and 10 nM) and TNF-a (0.1, 1.0 and 10 nM), alone and in combination, on e osinophil adhe sion to ASMC w ere ex amined by adding the cytokine s, or their ve hicle, to duplic ate slide-w ells containing the ASMC 24 h be fore or at the same time as the e osinophils. The eosinophils w e re c o-c ulture d w ith the ASMC, in the pre sence of the cytokines, for 2 or 20 h and then the slidew ells w ere proc essed. As a result of these treatme nt protocols the ASMC w e re tre ated w ith c ytokine for a total of 2 or 26 h w hen the eosinophils w ere prese nt for only 2 h and for 20 or 44 h w he n the eosinophils w ere present for 20 h.
IL-5.
The effe ct of IL-5 on e osinophil adhe sion to ASMC w as ex amined by adding the IL-5 (10 and 100 ng /ml), or its vehic le , to duplicate slide-w ells c ontainin g ASMC w hen the eosinophils w e re added. The cells w e re cocultured in the prese nce of the IL-5 for 2 or 20 h and then the slide-w e lls w ere proc essed as de scribe d earlie r.
The combined effe ct of IL-5 and TNF-a on eosinophil adhesion to ASMC w as also ex amined. ASMC in duplic ate slide-w ells w ere pre-treated w ith TNF-a (10 nM) for 24 h prior to the addition of the e osinophils and IL-5 (10 and 100 ng /ml). Afte r 2 h of c oculture in the pre senc e of both the TNF-a and IL-5, the slide w e lls w ere processed (ASMC TNF-a ex posure= 26 h ).
Data analysis
The counts (2 counts of 10 fields e ach per w ell) of eosinophils attached to ASMC p er 10 fields of view for the duplicate w ells re ce iving e ach tre atment w ere ave rage d. The number of e osinophils attached to ASMC w ere standardised in each ex periment. For the time c ourse ex pe riments the data for e ach ex perime nt w ere ex pressed as a pe rcentage of the maximum number of eosinophils attache d to ASMC per 10 fie lds of view. In the re maining ex periments the data for each ex perime nt w e re ex pressed as a pe rcentage of the untre ate d c ontrol. 
Results
Time course
Eosinophils adhe re d rapidly to ASMC, w ith maximum numbe rs be ing obse rved in most ex periments by 2 h of co-culture. The numbers of attache d eosinophils the n declined to 49.4± 8.9% of max imum by 20 h (Fig. 1 ) .
Adhesion molecule identification
Antib odie s to the adhesion molec ule s ICAM-1 and VCAM-1 reduced eosinophil attachment to ASMC. Pretre atment of ASMC w ith anti-ICAM-1 (3 and 10 m g /ml) for 30 min prior to and during a 20 h co-c ulture period w ith eosinophils significantly (p< 0.05, n = 4 ) reduce d eosinophil attachme nt to the ASMC to 77.0± 3.3% and 74.3± 5.0% of the untreated c ontrol respective ly (Fig.  2a ) , w he reas anti-VCAM-1 had no effect (Fig. 2b ) . With a shorte r 2 h c o-culture pe riod, the re w as more variability in eosinophil attachment, partic ularly in the presenc e of anti-ICAM-1 and the isotype c ontrol antibody (Fig. 2c ) . Anti-ICAM-1 (3 m g /ml) had no significant effect but anti-VCAM-1 (3 m g /ml) did significantly (p < 0.05, n = 4 ) re duce e osinophil attachme nt to ASMC (71.7± 4.2% of the untre ate d control) compared w ith the isotype c ontrol (118.6± 16.6% of the untreate d c ontrol) (Fig. 2c ) .
Effects of cytokines
IL-1b a n d TNF-a .
IL-1b had a small effect on eosinophil attachment to ASMC, 10 nM IL-1b reduced eosinophil attachme nt significantly to 81.1± 8.2% of the untre ated c ontrol compared w ith 92.8± 0.8% in the ve hicle c ontrol
(p< 0.05, n = 4 ) w hen pre sent for the 20 h co-culture period (20 h treatme nt) (Fig. 3a ) . All three c oncentrations of IL-1b w ere w ithout effec t, c ompared to the vehic le c ontrol, w hen added to the ASMC 24 h prior to the addition of the eosinophils and left the re for the 20 h co-c ulture pe riod (44 h treatment) (Fig. 3a ) .
In contrast to the se obse rvations, TNF-a inc re ase d eosinophil attachme nt to ASMC w ith e ithe r protoc ol (20 or 44 h treatme nt). TNF-a , 0.1 nM and 10 nM, added for the 20 h co-c ulture pe riod, significantly (p< 0.05, n = 3 ) increased e osinop hil attachme nt to 128.1± 14.2% and 139.8± 4.0% of the untreated control c omp ared w ith 92.4± 6.2% in the vehicle c ontrol but these increases w ere not significantly differe nt (Fig. 3b ) . TNF-a , 1.0 and 10 nM, w hen adde d to the ASMC 24 h prior to the 20 h c o-c ulture period (44 h tre atment), also significantly (p< 0.05, n = 3 ) increase d eosinophil attachme nt in a conc entration-depe nde nt manner (0.1 vs 1.0 nM and 1.0 vs 10 nM p< 0.05, n = 3 ) to 119.6± 9.1% and 156.5±5.2% of c ontrol re spec tively (Fig. 3b ) .
TNF-a inc reased e osinophil attachment to ASMC w hen the co-culture period w as shortene d to 2 h. TNF-a (10 nM) added 24 h before the 2 h co-culture period w as started (26 h tre atment ), significantly (p< 0.05, n = 4 ) increased e osinop hil attachme nt to 148.9± 13.2% of the untreated c ontrol, w hereas IL-1b w as w ithout effec t (112.3± 12.2%, n = 4 ). Ne ither 10 nM TNF-a , nor 10 nM IL-1b , had an effect w hen added for the co-culture pe riod only (117± 10.9% and 91± 9.7% of untre ated c ontrol respec tively, n = 4 ).
IL-1b (10 nM) did not modulate the inc rease in eosinophil attachment to ASMC induce d by the 26 h tre atment w ith 10 nM TNF-a . It had no effe ct, w hether adde d w ith the TNF-a (26 h tre atment ) or only for the 2 h co-c ulture pe riod (data not show n ).
IL-5.
IL-5 did not modulate eosinophil attachment to ASMC under the various c onditions tested. IL-5 (10 and 100 ng /ml) adde d at the same time as the eosinophils, had no signific ant effe ct on e osinophil attachment to ASMC follow ing 20 h of c o-c ulture (101.0± 17.6% and 91.9± 10.6% re spec tively, n = 3 ) (Fig.4a ) . It w as also w ithout effe ct w he n the c o-c ulture period w as shortened to 2 h (Fig. 4b ) . The re w as also no adde d effect of IL-5 under c onditions w he re TNF-a inc rease d eosinophil attachme nt (Fig. 4b ) .
Discussion
In this study w e demonstrate for the first time that human eosinophils c an rapidly attach to human airw ay smooth muscle ce lls. Max imum numbers of attached eosinophils w ere observe d afte r around 2 h, w ith numbe rs falling to half that le ve l by 20 h of c oculture. Eosinophil attachment to ASMC at 2 h w as significantly re duc ed in the pre senc e of an antibody to the adhe sion molec ule VCAM-1, w hile at 20 h it w as significantly re duc ed in the pre senc e of an antibody to ICAM-1. The pro-inflammatory cytokine TNF-a significantly inc reased the number of attached e osinophils, w here as IL-1b and IL-5 w e re w ithout effec t.
Eosinophils have be en show n to attach very rapidly to e ndothelial ce lls, reaching max imum numbers after 5 min of co-culture. 1 4 The y also adhe re quickly to epithe lial c ells w ith c o-c ulture pe riods of 30-60 min commonly being used. 15 ,16 We hypothesized that eosinophils w ould also adhere rap idly to ASMC and found that max imum numbers w ere re ache d in the first 2 h and that substantial numbers w e re still attached after 20 h of co-culture. It w ould appe ar from our obse rvations, compare d w ith those of Munoz and colleagues, 1 4 that eosinophils attach more slow ly to ASMC than the y do to e ndothelial ce lls, as attache d eosinophil numbers w ere only around 50% of maximum afte r 30 min.
We inve stigated w hether the adhe sion molec ule s ICAM-1 and VCAM-1 w ere involve d in eosinophil adhesion to ASMC bec ause the y are both constitutively ex pre sse d on ASMC and have been show n to participate in the attachment of ac tivated lymphocytes to ASMC.
1 ICAM-1 and VCAM-1 both play important roles in eosinophil adhesion to and transmigration through vasc ular e ndothelium. 17 Intere stingly, although ICAM-1 is ex p re sse d on e pithe lial c ells, only eosinophils activated w ith C5a, PMA or eotax in (but not RANTES, MIP-1 a , FMLP, LTB 4 , or PAF -activate d ce lls ) adhere in an ICAM-1 depe ndent manne r. 15 ,16 ,1 8 Our in vitro data are consistent w ith the hypothe sis that VCAM-1 is important in the initial adhesion to ASMC, as antibodies to it signific antly reduced the number of attached eosinophils at 2 h, but not at 20 h. The y are also c onsistent w ith the hypothe sis that ICAM-1 is involve d in prolonge d eosinophil adhesion to ASMC, as an antibody to ICAM-1 significantly reduced attached eosinophil numbers after 20 h of coculture. How e ve r, ne ithe r of the antibodie s inhibite d eosinophil attachme nt by more than 28%, so other molecules must also be involved in both the initia l phase and during prolonged adhe sion.
Ele vated le vels of cytokine s TNF-a and IL-1b have bee n found in the airw ays of asthmatic subjec ts. 1 9,2 0 Macrophages, other immune c ells and e pithe lial cells all produce TNF-a . How e ve r, mast ce lls not only synthesize TNF-a , but also store it in their granules and so are able to re le ase it imme diate ly follow ing ex posure to antige n. 20 Inte re stingly, in the airw ays, mast cell numbe rs are highe st in the smooth muscle layer.
2 1 IL-1b is also produc ed by a w ide range of immune and structural c ells but the main sourc e follow ing antige n ex posure is the mac rop hage. 2 2 The c ytokine s TNF-a and IL-1b have be en show n to affec t many ASMC func tions. IL-1b pote ntiated proliferation of guinea-pig ASMC 10 and TNF-a stimulate d human ASMC proliferation at low conce ntration s and w as inhibitory at highe r c once ntrations. 9 The se cytokines also stimulate d ASMC sec re tion of a variety of othe r cytokines and chemokines, including some like GM-CSF, eotax in and RANTES (regulate d on ac tivation normal T-cells ex pre sse d and sec re te d ), 11 ,1 2,2 3 w ith dire ct e ffec ts on e osinophil rec ruitment, activation and viability. 17 In addition, Lazaar and c olleagues 1 demonstrate d that TNF-a and IL-1b also increase d the ce ll surface ex pression of ICAM-1 and VCAM-1 on human ASMC. Most importantly the y found that activated T-lymphoc ytes could the n attach to the ASMC and induce ASMC proliferation. Thus ASMC are influenc ed by their inflammatory e nvironment and may contribute further to the inflammation, re gulating it locally and attracting more inflammatory ce lls to the muscle layer. An additional finding of this study w as that TNF-a also inc reases the adhesion of human eosinophils to human ASMC. TNF-a , 10 nM, incre ase d the numbe r of eosinophils attaching during the first 2 h of co-culture only if the ASMC had bee n tre ated w ith it for 24 h prior to the addition of the eosinophils, w here as w ith an ex te nded co-culture period (20 h ), it alw ays inc re ased the numbe r of adhesive ce lls w he ther or not the ASMC had bee n treate d w ith it for 24 h be fore. When TNF-a (0.1 -10 nM) w as present for the ex tended c o-c ulture p eriod (20 h ) only, it incre ased e osinophil adhe sion pe riod to the ASMC in a c oncentrationindepe nde nt manner. How e ve r, w hen a 24 h pretre atment pe riod w ith TNF-a w as also include d (44 h tre atment ), e osinop hil adhe sion w as increase d in a c once ntration-dep endent manner. This appare nt difference in effe cts of TNF-a may be due to timerelated responses to diffe rential rec ruitment of the p55 and p75 TNF-a re ce ptors on the ASMC and /or the eosinophils by the low er conce ntration s of TNF-a . Prolonged tre atment w ith TNF-a may inc re ase adhesive e osinophil numbe rs by inc reasing ASMC adhesion molec ule ex pre ssion, as already demonstrate d for lymphoc yte adhesion to ASMC. 1 IL-1b , on the other hand, w as w ithout significant effect on e osinophil adhesion to the ASMC under all conditions, ex ce pt w hen present for just the 20 h c oculture period. In this instance only, it cause d a slight (19%) but significant reduction in the level of eosinophil adhe sion. This lack of (or inhibitory) effe ct of IL-1b w as unex pec te d as, like TNF-a , IL-1b has bee n show n to inc re ase the ex pre ssion of both VCAM-1 and ICAM-1 on ASMC follow ing a 24 h treatme nt period.
1 How e ve r, unlike TNF-a , IL-1b also induc es ASMC to release PGE 2 .
2 4,2 5 Therefore , it is possible that PGE 2 released during the IL-1b tre atment period, might have alte re d the re sponse(s ) of either c ell-type and so negated any dire ct e ffec ts of IL-1b that might othe rw is e have led to increased eosinophil adhesion to the ASMC under the conditions reported he re.
IL-5 w as also w ithout an effe ct on eosinophil adhesion to the ASMC in this study. The IL-5 used w as biologically active as it increase d eosinophil survival w hen c ulture d alone for 24 h by up to 27% (data not show n ). As w e ll as promoting eosinophil differentiation, grow th, migration and survival, IL-5 has bee n show n to induc e e osinophil morphologic al changes rapidly 2 6 and to enhanc e eosinophil adhesion to immobilised ICAM-1 and VCAM-1 27 and to e ndothelial c ells in an integrin-depe ndent (CD11 /18 ) manne r 28 in v itro . Ex trace llular matrix prote ins may also me diate eosinophil adhe sion to ASMC as inte grins bind to the m and CD44, a mole cule w hich binds to the matrix prote in hyaluronate , plays an important role in lymphoc yte adhesion to ASMC. 1 How ever, despite inc re asing eosinophil surfac e ex pression of CD44 w ith a 24 h IL-5 tre atment, Matsumoto e t a l. did not obse rve increased e osinophil adhe sion to immobilised hyaluronate follow ing IL-5 tre atment. 29 Under the c onditions re porte d in this study, any IL-5 induced changes may not be of the nature require d, or sufficie nt, to suc ce ssfully increase eosinophil adhesion to ASMC, e ve n w he n TNF-a doe s increase it.
Many studie s have show n that eosinophil mediator release is induc ed and modulated by interac tions betw e en eosinophil adhe sion molecules and their counte r-ligands or ex trac ellular matrix prote ins. 30 -3 4 Interestingly, ASMC production of some ex tracellular matrix prote ins is increased follow ing ex posure to se rum from an atopic asthmatic . 35 Adhe re nt e osinophils in the airw ay smooth muscle layer are there fore like ly to rele ase mediators. Once activate d, e osinophils may produce an ex te nsive range of cytokines and grow th factors, including IL-1b , TNF-a , PDGF, FGF, TGF-b , that have be en implic ate d in modulating ASMC proliferation 3,9 ,1 0 and /or me diator production. 4 ,11 ,12 The effec t on the muscle ce lls of eosinophil adhesion to the m w ill vary, de pending on the balanc e of the many inflammatory mediators pre sent and the se verity of the allergic resp onse at the time.
TNF-a is like ly to be pre se nt before and afte r eosinophils re ach the smooth muscle layer of asthmatic airw ays and, of course, is like ly to modulate eosinophil behaviour, as w ell as that of the ASMC, and so regulate the ir inte raction. Studies in vitro have demonstrate d that TNF-a -tre ated e osinophils have enhance d survival, up-re gulated surface ex pre ssion of the activation marke r CD69, 36 incre ased adhe sion to immobilised ICAM-1 and VCAM-1, 2 7 as w ell as degranulation, leukotriene C 4 and supe rox ide production. 2 6,3 7,3 8 Granule proteins cause tissue damage in v itro and have been implic ate d in epithelial shedding in vivo . 17 We obse rved incre ase d eosinophil adhesion to ASMC w ith no sign of ASMC detachment or overt morphological damage w ith eosinophil ex posure s to TNF-a of 2 or 20 h. This is the first study of e osinophil adhesion to airw ay smooth muscle ce lls. We have show n that adhesion is rapid and can be prolonged. As w e found it is partially me diate d through ICAM-1 and VCAM-1, it is like ly to re sult in e osinophil mediator re le ase and altered airw ay smooth muscle re sponses. We have also demonstrate d that the c ytokine TNF-a inc re ases eosinophil adhe sion to the smooth muscle c ells at conc entrations that also induce airw ay smooth muscle to se crete othe r pro-inflammatory c ytokine s and che mokines. It is there fore possible that e osinophils and ASMC may re gulate e ach other's response s and inflammation loc ally in asthmatic airw ays, contributing to the p athoge nesis and symptoms of asthma.
